bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • EyePoint Pharmaceuticals Inc. logo

    EyePoint Pharmaceuticals Inc.

    EYPT | NASDAQ
    Chart Builder DCF Calculator
    $4.10
    +$0.08 (+1.99%)
    Sep 22, 2026, 12:28 PM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $337.04M
    Enterprise Value
    $178.94M
    Beta
    1.64
    Average Volume
    2.6M
    Shares Outstanding (Diluted)
    86.54M
    Shares Change YoY
    23.76%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US30233G2093

    Price Performance

    Price Change 1M
    -22.2%
    Price Change 3M
    -72.0%
    Price Change 6M
    -69.2%
    Price Change YTD
    -77.0%
    Price Change 1Y
    -69.9%
    Price Change 3Y
    -52.4%
    Price Change 5Y
    -65.7%
    1M CAGR (ann.)
    -71.1%
    1Y CAGR (ann.)
    -70.8%
    5Y CAGR (ann.)
    -16.7%
    All-Time CAGR
    -14.4%

    Valuation

    PE Ratio
    -1.07
    Forward PE
    N/A
    PEG Ratio
    0.04
    Forward PEG
    0.04
    PS Ratio
    120.85
    Forward PS
    18.80
    PB Ratio
    2.03
    P/FCF Ratio
    -0.96
    P/Adj. FCF Ratio
    -0.84
    P/OCF Ratio
    -1.30
    EV/Sales
    64.16
    EV/EBIT
    -0.60
    EV/EBITDA
    -0.61
    EV/FCF
    -0.51
    Earnings Yield
    -93.0%
    FCF Yield
    -104.7%
    Adj. FCF Yield
    -118.6%

    Financial Health

    Net Cash
    $180.47M
    Total Debt
    $22.37M
    Cash & Short-Term Investments
    $180.47M
    Total Assets
    $228.19M
    Current Ratio
    4.50
    Quick Ratio
    4.46
    Debt / Equity Ratio
    0.13
    Debt / EBITDA
    -0.08
    Debt / FCF
    -0.06
    OCF / Debt
    -15.55
    Interest Coverage
    0.00
    Altman Z-Score
    -8.13
    Piotroski F-Score
    1

    Margins & Profitability

    Gross Profit Margin
    41.8%
    Operating Profit Margin
    -11365.2%
    EBITDA Margin
    -10556.1%
    Net Profit Margin
    -10994.7%
    FCF Margin
    -12650.6%
    Adj. FCF Margin
    -14330.4%
    SBC / Revenue
    1262.6%
    SBC Impact (per share)
    -13.3%

    Returns

    Return on Assets
    -134.4%
    Return on Equity
    -135.8%
    Return on Invested Capital
    -167.8%
    Return on Capital Employed
    -170.2%
    Return on Tangible Assets
    -134.4%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -57.9%
    Revenue CAGR 5Y
    -41.0%
    Revenue CAGR 10Y
    5.6%
    EPS CAGR 3Y
    -35.6%
    EPS CAGR 5Y
    -7.8%
    EPS CAGR 10Y
    14.3%
    FCF CAGR 3Y
    -60.5%
    FCF CAGR 5Y
    -56.4%
    FCF CAGR 10Y
    -30.2%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    20
    EPS Growth Next 3Y
    34.3%
    Revenue Growth Next 3Y
    439.3%
    Earnings Date
    Nov 3, 2026
    EPS Estimate (next Q)
    -$0.91
    EPS Growth Est (next Q)
    6.5%
    Revenue Est (next Q)
    $231.15K
    Revenue Growth Est (next Q)
    -76.1%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $18.29
    Price Target Upside
    355.0%

    Cash Flow

    Operating Cash Flow
    $-347.85M
    Free Cash Flow
    $-352.83M
    Adj. Free Cash Flow
    $-399.68M
    FCF Per Share
    -$3.13
    OCF Per Share
    -$3.09
    OCF/S Ratio
    -9584.0%

    Income Statement

    Revenue
    $2.79M
    Gross Profit
    $1.17M
    Operating Income
    $-316.98M
    EBITDA
    $-294.41M
    Net Income
    $-306.64M
    EPS (Diluted)
    -$3.74
    Revenue / Employee
    $13.03K
    Profit / Employee
    $-1.43M
    Employees
    214

    © 2026 bestshares.com. All rights reserved.